XEPLION

This brand name is authorized in Austria, Cyprus, Estonia, Spain, Finland, France, Croatia, Ireland, Israel, Italy, Japan, Lithuania, Netherlands, Poland, Romania, Turkey, United Kingdom

Active ingredients

The drug XEPLION contains one active pharmaceutical ingredient (API):

1 Paliperidone UNII R8P8USM8FR - PALIPERIDONE PALMITATE

Paliperidone is a selective blocking agent of monoamine effects, whose pharmacological properties are different from that of traditional neuroleptics. Even though paliperidone is a strong D2-antagonist, which is believed to relieve the positive symptoms of schizophrenia, it causes less catalepsy and decreases motor functions to a lesser extent than traditional neuroleptics. Read about Paliperidone

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
XEPLION Prolonged release suspension for injection	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
N05AX13	Paliperidone	N Nervous system → N05 Psycholeptics → N05A Antipsychotics → N05AX Other antipsychotics
Discover more medicines within N05AX13

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1519534, 1519545, 1519556, 1519567, 1519578, 1519589
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 11672002, 11672003, 11672004, 11672005
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 058609, 409745, 412581, 536460
Country: FR	Base de données publique des médicaments	Identifier(s): 60713079, 64760254, 65554816, 66614262, 68716209
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 192091, 192101, 192107, 192110
Country: IE	Health Products Regulatory Authority	Identifier(s): 34251, 34252, 34253, 34254
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 6715, 6716, 6717, 6718
Country: IT	Agenzia del Farmaco	Identifier(s): 041004019, 041004021, 041004033, 041004045, 041004058, 041004060
Country: JP	医薬品医療機器総合機構	Identifier(s): 1179409G1025, 1179409G2021, 1179409G3028, 1179409G4024, 1179409G5020, 1179409G6027, 1179409G7023, 1179409G8020, 1179409G9026
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1059526, 1059552, 1059553, 1059554, 1059555, 1059556
Country: NL	Z-Index G-Standaard	Identifier(s): 15641937
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 100218, 96954, 96962, 96970, 96989, 96997
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100245661, 100245678, 100245684, 100245690, 100245709, 100245715
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W57256001, W57257001, W57258001, W57259001, W57260001
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699593950049, 8699593950056, 8699593950063, 8699593950070